Impact Factor
2.48
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.98
151 total citations
h5-index
15
h5 depth signal
Cited share
48.4%
78 of 161
Total citations
151
Citation footprint
Metric signal
1.23
External metric anchor
Self-citation
6.0%
9 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Russia
585
Spain
9
Belarus
9
Italy
8
United Kingdom
6
Citing Fields of Research
Endocrinology & Metabolism
369
Diabetes
175
Adrenal Dysfunction
93
Endocrine Therapy
85
Osteopathies
77
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,981
Articles tracked across the journal lifetime
Indexed publication set
161
78 cited publications
Last 12 months
75
12.5 publications/month
Open access share
98.7%
74 OA publications in the last year
Leading citing country
Russia
585 citing publications
Leading citing field
Endocrinology & Metabolism
369 citing publications
Latest tracked publication
8 September 2026
10 recent records available
Coverage & Indexing History
v13n1, Jan./Feb. 1967-v40n6, Nov./Dec. 1994; v65n1, 2019-
v13n1, Jan./Feb. 1967-v40n6, Nov./Dec. 1994; v65n1, 2019-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Endocrinology & Metabolism
Diabetes
Adrenal Dysfunction
Osteopathies
Issuing & Sponsoring Bodies
Contributor
Soviet Union. Ministerstvo zdravookhranenii︠a︡
Broad Categories
Endocrinology
Endocrinology & Metabolism
Diabetes
Osteopathies
Adrenal Dysfunction
Human Reproduction
MeSH Descriptors
Endocrinology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.14341/probl13823
Open DOI
Clinical practice guidelines "Congenital hyperinsulinism"
Congenital hyperinsulinism (CHI) is a rare, genetically heterogeneous disorder characterized by inappropriate hypersecre tion of insulin by pancreatic beta cells and is the most common cause of persistent hypoglycemia in young children. ...
02
DOI 10.14341/probl13780
Open DOI
Growth hormone and fertility: molecular mechanisms and experience of adjuvant therapy in reproductology
Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) are pivotal hormones regulating not only postnatal growth, development, aging, and longevity but also female reproductive function. In clinical practice, GH is widely utilized ...
03
DOI 10.14341/probl13774
Open DOI
The unbearable versatility of endocrine aging
Ageing is multifactorial, genetically and epigenetically programmed biological process. Nowadays ageing is acknowledged as extremely actual scientifical, social and demographical problem. Despite the evidence of interactions between agei...
04
DOI 10.14341/probl13713
Open DOI
Normophosphatemic familial tumoral calcinosis: description of a case with phosphate lowering therapy
Normophosphatemic familial tumoral calcinosis (NFTC) is characterized by cutaneous calcifications with no metabolic disorders; it manifests in the first years of life; associated with mutations in SAMD9 gene. Chronic trauma and transient...
05
DOI 10.14341/probl13702
Open DOI
Prognostic research in endocrinology: design and common errors
This article provides a conceptual overview of the methodology and design of prognostic research. It presents cohort studies as the most suitable design for prognostic investigations and discusses in detail the distinctions between tradi...
06
DOI 10.14341/probl13688
Open DOI
Thyrotoxic crisis in a patient with coexisting Graves’ disease and type 1 diabetes mellitus
Thyrotoxic crisis (TC) is a rare but potentially life-threatening complication of decompensated thyrotoxicosis that requires immediate medical intervention. The diagnosis of TC is based on a clinical picture of severe hyperthyroidism in ...
07
DOI 10.14341/probl13684
Open DOI
Association of vitiligo with endocrine autoimmune diseases: literature review
Vitiligo is a dermatological disease characterized by focal disappearance of the melanin pigment on the skin and mucous membranes of a person. Despite the variety of proposed hypotheses for the development of this pathology, the central ...
08
DOI 10.14341/probl13606
Open DOI
The effects of methylprednisolone pulse therapy on glucose metabolism parameters in children with autoimmune and autoinflammatory diseases
BACKGROUND:
The use of glucocorticosteroids (GCS) in high doses can lead to hyperglycemia. GCS pulse therapy (PT) cause fewer side effects compared to long-term oral administration of GCS in adult patients. Glycemic ...
09
DOI 10.14341/probl13817
Open DOI
Hair loss during treatment of obesity: current state of the problem and potential solutions
Obesity and overweight are significant medical and social problems, and current approaches to their treatment, including hypocaloric diets, bariatric interventions, and pharmacotherapy, including incretin drugs (e.g., glucagon-like pepti...
10
DOI 10.14341/probl13805
Open DOI
Resolution of the Joint Meeting of the Expert Council "Hypoparathyroidism in the Era of Complex Problems and Breakthrough Technologies"
On March 25, 2026, a meeting of the Expert Council entitled "Hypoparathyroidism in the Era of Complex Challenges and Breakthrough Technologies" was held in Moscow at the Endocrinology Research Centre. The meeting focused on the epidemiol...
Bibliographical & Catalog Notes
Issues for <2015- > have English parallel title: Problems of endocrinology.
At head of title, 1967- Ministerstvo zdravookhranenii︠a︡ SSSR.
Also issued online.
Added table of contents and summaries in English. Search interface in English and Russian.
Issued by: FGBU "Ėndokrinologicheskiĭ nauchnyĭ t︠s︡entr Minzdrava RF; and, OO Rossiĭskai︠a︡ assot︠s︡iat︠s︡ii︠a︡ ėndokrinologov.